Bilateral volume reduction in posterior hippocampus in psychosis of epilepsy.


Journal

Journal of neurology, neurosurgery, and psychiatry
ISSN: 1468-330X
Titre abrégé: J Neurol Neurosurg Psychiatry
Pays: England
ID NLM: 2985191R

Informations de publication

Date de publication:
06 2019
Historique:
received: 06 08 2018
revised: 07 12 2018
accepted: 21 01 2019
pubmed: 24 2 2019
medline: 14 3 2020
entrez: 24 2 2019
Statut: ppublish

Résumé

Psychosis of epilepsy (POE) occurs more frequently in temporal lobe epilepsy, raising the question as to whether abnormalities of the hippocampus are aetiologically important. Despite decades of investigation, it is unclear whether hippocampal volume is reduced in POE, perhaps due to small sample sizes and methodological limitations of past research. In this study, we examined the volume of the total hippocampus, and the hippocampal head, body and tail, in a large cohort of patients with POE and patients with epilepsy without psychosis (EC). One hundred adults participated: 50 with POE and 50 EC. Total and subregional hippocampal volumes were manually traced and compared between (1) POE and EC; (2) POE with temporal lobe epilepsy, extratemporal lobe epilepsy and generalised epilepsy; and (3) patients with POE with postictal psychosis (PIP) and interictal psychosis (IP). Compared with EC the POE group had smaller total left hippocampus volume (13.5% decrease, p<0.001), and smaller left hippocampal body (13.3% decrease, p=0.002), and left (41.5% decrease, p<0.001) and right (36.4% decrease, p<0.001) hippocampal tail volumes. Hippocampal head volumes did not differ between groups. Posterior hippocampal volumes are bilaterally reduced in POE. Volume loss was observed on a posteroanterior gradient, with severe decreases in the tail and moderate volume decreases in the body, with no difference in the hippocampal head. Posterior hippocampal atrophy is evident to a similar degree in PIP and IP. Our findings converge with those reported for the paradigmatic psychotic disorder, schizophrenia, and suggest that posterior hippocampal atrophy may serve as a biomarker of the risk for psychosis, including in patients with epilepsy.

Identifiants

pubmed: 30796132
pii: jnnp-2018-319396
doi: 10.1136/jnnp-2018-319396
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

688-694

Commentaires et corrections

Type : CommentIn

Informations de copyright

© Author(s) (or their employer(s)) 2019. No commercial re-use. See rights and permissions. Published by BMJ.

Déclaration de conflit d'intérêts

Competing interests: None declared.

Auteurs

James Allebone (J)

Melbourne School of Psychological Sciences, University of Melbourne, Melbourne, Victoria, Australia james.allebone@unimelb.edu.au.
The Florey Institute of Neuroscience and Mental Health, Parkville, Victoria, Australia.

Richard Kanaan (R)

The Florey Institute of Neuroscience and Mental Health, Parkville, Victoria, Australia.
Department of Psychiatry, Austin Health, University of Melbourne, Melbourne, Victoria, Australia.

Jerome Maller (J)

ANU College of Health and Medicine, Australian National University, Canberra, Victoria, Australia.
Monash Alfred Psychiatry Research Centre, The Alfred and Monash University, Melbourne, Victoria, Australia.

Terry O'Brien (T)

Royal Melbourne Hospital, Melbourne, Victoria, Australia.
Department of Neuroscience, Alfred Hospital, Monash University, Melbourne, Victoria, Australia.

Saul Alator Mullen (SA)

The Florey Institute of Neuroscience and Mental Health, Parkville, Victoria, Australia.

Mark Cook (M)

Graeme Clark Institute, University of Melbourne, Melbourne, Victoria, Australia.

Sophia J Adams (SJ)

Royal Melbourne Hospital, Melbourne, Victoria, Australia.

Simon Vogrin (S)

St Vincent's Hospital, Melbourne, Victoria, Australia.

David N Vaughan (DN)

The Florey Institute of Neuroscience and Mental Health, Parkville, Victoria, Australia.
Comprehensive Epilepsy Program, Austin Health, University of Melbourne, Melbourne, Victoria, Australia.

Alan Connelly (A)

The Florey Institute of Neuroscience and Mental Health, Parkville, Victoria, Australia.
Comprehensive Epilepsy Program, Austin Health, University of Melbourne, Melbourne, Victoria, Australia.

Patrick Kwan (P)

Royal Melbourne Hospital, Melbourne, Victoria, Australia.
Department of Neuroscience, Alfred Hospital, Monash University, Melbourne, Victoria, Australia.

S F Berkovic (SF)

Comprehensive Epilepsy Program, Austin Health, University of Melbourne, Melbourne, Victoria, Australia.

Wendyl J D'Souza (WJ)

Department of Medicine, St Vincent's Hospital, The University of Melbourne, Melbourne, Victoria, Australia.

Graeme Jackson (G)

The Florey Institute of Neuroscience and Mental Health, Parkville, Victoria, Australia.
Comprehensive Epilepsy Program, Austin Health, University of Melbourne, Melbourne, Victoria, Australia.

Dennis Velakoulis (D)

Neuropsychiatry Unit, Royal Melbourne Hospital, Melbourne, Victoria, Australia.
Melbourne Neuropsychiatry Centre, University of Melbourne and Melbourne Health, Melbourne, Victoria, Australia.

Sarah J Wilson (SJ)

Melbourne School of Psychological Sciences, University of Melbourne, Melbourne, Victoria, Australia.
The Florey Institute of Neuroscience and Mental Health, Parkville, Victoria, Australia.
Comprehensive Epilepsy Program, Austin Health, University of Melbourne, Melbourne, Victoria, Australia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH